News & AnalysisBiopharma startup Vivodyne pulls in $4m seedBiopharma startup Vivodyne has raised $4 million in seed funding.ByIris Dorbian29 March 2021•3 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs